APA

Murri R., Fantoni M., Del Borgo C., Izzi I., Visonà R., Suter F., Banfi M. C., Barchi E., Orchi N., Bosco O. & Wu A. W. (20000907). Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. : Journal of acquired immune deficiency syndromes (1999).

Chicago

Murri R, Fantoni M, Del Borgo C, Izzi I, Visonà R, Suter F, Banfi M C, Barchi E, Orchi N, Bosco O and Wu A W. 20000907. Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. : Journal of acquired immune deficiency syndromes (1999).

Harvard

Murri R., Fantoni M., Del Borgo C., Izzi I., Visonà R., Suter F., Banfi M. C., Barchi E., Orchi N., Bosco O. and Wu A. W. (20000907). Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. : Journal of acquired immune deficiency syndromes (1999).

MLA

Murri R, Fantoni M, Del Borgo C, Izzi I, Visonà R, Suter F, Banfi M C, Barchi E, Orchi N, Bosco O and Wu A W. Intravenous drug use, relationship with providers, and stage of HIV disease influence the prescription rates of protease inhibitors. : Journal of acquired immune deficiency syndromes (1999). 20000907.